{"id":"c390bada-7d06-559f-88fe-77525965c8af","stable_key":"3b5aff9b-4086-5574-bfb4-3ea49ba520d7:coq10-migraine-adult","predicate":"reduced_trial_frequency_of","statement":"The 50% responder rate for attack frequency was 47.6% with CoQ versus 14.4% with placebo in the third treatment month.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"a4061ce7-f368-56b5-8fac-dc670246b91b","mechanism_event_label":"A small migraine trial reported fewer attacks.","subject":{"id":"f1bcf0ac-3578-5afa-97d7-ef3551b657c5","slug":"coq10","display_name":"Coenzyme Q10 / CoQ10 redox system","entity_type_key":"chemical_species"},"object":{"id":"b7c15223-a4df-5d22-806a-01d8bc86b2a9","slug":"migraine-attack-frequency","display_name":"Migraine attack frequency","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"a4061ce7-f368-56b5-8fac-dc670246b91b","stable_key":"3b5aff9b-4086-5574-bfb4-3ea49ba520d7:coq10-migraine-adult-event","event_type":"observed_intervention","label":"A small migraine trial reported fewer attacks.","description":"The 50% responder rate for attack frequency was 47.6% with CoQ versus 14.4% with placebo in the third treatment month.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"f1bcf0ac-3578-5afa-97d7-ef3551b657c5","slug":"coq10","display_name":"Coenzyme Q10 / CoQ10 redox system","entity_type_key":"chemical_species"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"b7c15223-a4df-5d22-806a-01d8bc86b2a9","slug":"migraine-attack-frequency","display_name":"Migraine attack frequency","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/coq10-research/15728298.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"efc7a89a0f36fb7248716b6a3e951d719b4e7f2c1051cd8ea50b61a1f4e4941f\", \"start_char\": 0, \"end_char\": 533, \"text_sha256\": \"efc7a89a0f36fb7248716b6a3e951d719b4e7f2c1051cd8ea50b61a1f4e4941f\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Double-blind randomized placebo-controlled trial","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"CoQ10 100 mg three times daily","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Small preventive trial; third-month endpoint, not proof of correction of a diagnosed CoQ deficiency.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Coenzyme Q10 research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"coq10","display_name":"Coenzyme Q10 / CoQ10 redox system","entity_type_key":"chemical_species"}},{"dimension":"organism","value_text":"42 migraine patients","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"A small migraine trial reported fewer attacks.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[coq10-p15728298] Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. (2005). https://pubmed.ncbi.nlm.nih.gov/15728298/ DOI: 10.1212/01.wnl.0000151975.03598.ed","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Attack frequency and headache days","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"d04ee2ec-f97b-5d76-9e09-b64e043e206e","evidence_kind":"source_excerpt","locator":"Lines 1191-1202","start_line":1191,"end_line":1202,"excerpt":"### coq10-migraine-adult\nThe 50% responder rate for attack frequency was 47.6% with CoQ versus 14.4% with placebo in the third treatment month.\nCondition category: normal\nnutrient_topic: Coenzyme Q10 research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: A small migraine trial reported fewer attacks.\norganism: 42 migraine patients\ntissue_or_cell_type: Attack frequency and headache days\nexperimental_model: Double-blind randomized placebo-controlled trial\nlimitations: Small preventive trial; third-month endpoint, not proof of correction of a diagnosed CoQ deficiency.\nexposure: CoQ10 100 mg three times daily\nevidence_span: {\"source_cache\": \"artifacts/coq10-research/15728298.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"efc7a89a0f36fb7248716b6a3e951d719b4e7f2c1051cd8ea50b61a1f4e4941f\", \"start_char\": 0, \"end_char\": 533, \"text_sha256\": \"efc7a89a0f36fb7248716b6a3e951d719b4e7f2c1051cd8ea50b61a1f4e4941f\"}\n[coq10-p15728298] Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. (2005). https://pubmed.ncbi.nlm.nih.gov/15728298/ DOI: 10.1212/01.wnl.0000151975.03598.ed","model_system":"Double-blind randomized placebo-controlled trial","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [coq10-p15728298] Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. (2005). https://pubmed.ncbi.nlm.nih.gov/15728298/ DOI: 10.1212/01.wnl.0000151975.03598.ed","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"fc6c2f3b-14a3-59de-848e-ca1c02fee1df","stable_key":"import-3b5aff9b-4086-5574-bfb4-3ea49ba520d7","title":"Coenzyme Q10: biosynthesis, electron transfer, antioxidant recycling and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"053f9a6f6c17321fa9fd271486d7f20a86a49b237424108de7dc8663372e73bf","revision_id":"028900ce-8ca4-5d13-8c86-6e327c071e64","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}